Hasal, E. Et Al. 2022. Factors Related to Omalizumab Drug Survival and Treatment Responses in Chronic Urticaria. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , vol.183, no.11 , 1198-1208.

Hasal, E., BÜLBÜL BAŞKAN, E., YAZİCİ, S., AYDOĞAN, K., & SARICAOĞLU, H., (2022). Factors Related to Omalizumab Drug Survival and Treatment Responses in Chronic Urticaria. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , vol.183, no.11, 1198-1208.

Hasal, Eda Et Al. "Factors Related to Omalizumab Drug Survival and Treatment Responses in Chronic Urticaria," INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , vol.183, no.11, 1198-1208, 2022

Hasal, Eda Et Al. "Factors Related to Omalizumab Drug Survival and Treatment Responses in Chronic Urticaria." INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , vol.183, no.11, pp.1198-1208, 2022

Hasal, E. Et Al. (2022) . "Factors Related to Omalizumab Drug Survival and Treatment Responses in Chronic Urticaria." INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY , vol.183, no.11, pp.1198-1208.

@article{article, author={Eda Hasal Et Al. }, title={Factors Related to Omalizumab Drug Survival and Treatment Responses in Chronic Urticaria}, journal={INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY}, year=2022, pages={1198-1208} }